Stroke Care Completed B Round Financing of Nearly 100 Million Yuan
According to Yiou, on September 9, 2019, Stroke Care announced that it had got nearly 100 million yuan in B round of financing, led by Hidea Venture Capital, followed by Sharewin Investment and Grand Yangtze Capital.
This fund will be used to promote the clinical trials of new products in the four pipelines of Stroke Care, expand the market, industrialize the forthcoming products, and further improve the comprehensive solution including stroke prevention and treatment.
Founded in 2016, Stroke Care is located in Shanghai Zhangjiang High-Tech Park. The company focuses on the development of new minimally invasive interventional products for the prevention and treatment of ischemic stroke.
Stroke Care has four product lines for stroke prevention, acute stroke thrombolysis, stroke access, and stroke stenosis treatment. Its core products are left auricular occlusion (a percutaneous interventional device used to plug the structure of the heart, the intended use is to seal the left auricular and prevent thromboembolism from the left auricular) and Eruss thrombectomy system (a device suitable for acute ischemic stroke caused by occlusion of large arteries which can remove thrombus in large intracranial vessels in patients with ischemic stroke, so as to restore blood flow).
About Hidea Venture Capital
Hidea Venture Capital was founded in 2007, with the registered capital of 100 million yuan and the management capital of 5 billion yuan. The company mainly invests in medical health and intelligent manufacturing. Its team consists of the professionals engaged in equity investment in China, with nearly 20 years of equity investment management experience.
About Grand Yangtze Capital
Grand Yangtze Capital is an investment firm focused principally on equity investments in growth and expansion stage enterprises in China. They have been managing 7 PE and VC funds since 2007 and have deployed over 4 billion RMB.
Grand Yangtze Capital has invested in over 40 companies, among which 8 companies went public, and several others were merged or acquired.